Skip to content

Low-dose L-DOPA treatment for drug-induced dystonia

Low-dose L-DOPA treatment for drug-induced dystonia - Low-dose L-DOPA treatment for drug-induced dystonia

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000054201
Enrollment
9
Registered
2024-04-19
Start date
2024-04-18
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Drug-induced dystonia

Interventions

Patients who meet the selection criteria will be prescribed low doses of LDOPA.

Sponsors

Osaka Neurological Institute
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: The subjects in our study were patients diagnosed with drug-induced dystonia based on the DSM-V diagnostic criteria.

Exclusion criteria

Exclusion criteria: Other cases considered unsuitable for this study

Design outcomes

Primary

MeasureTime frame
Yale Brown Obsessive Compulsive Scale (Y-BOCS) Burke Fahn Marsden Dystonia Movement Scale (BFMDMS).

Countries

Japan

Contacts

Public ContactShinichi Matsumoto

Osaka Neurological Institute Neurolody

dyt1mc@yahoo.co.jp0663330086

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026